UnitedHealth Group Incorporated (NYSE:UNH) Holdings Decreased by Private Trust Co. NA

Private Trust Co. NA trimmed its position in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 22.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,509 shares of the healthcare conglomerate’s stock after selling 2,529 shares during the quarter. Private Trust Co. NA’s holdings in UnitedHealth Group were worth $4,339,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Norges Bank bought a new position in UnitedHealth Group during the 4th quarter worth $4,478,185,000. State Street Corp grew its stake in UnitedHealth Group by 1.9% during the 4th quarter. State Street Corp now owns 45,559,868 shares of the healthcare conglomerate’s stock worth $22,877,432,000 after buying an additional 869,827 shares during the last quarter. Marshall Wace LLP boosted its position in UnitedHealth Group by 2,853.0% during the 4th quarter. Marshall Wace LLP now owns 861,798 shares of the healthcare conglomerate’s stock worth $432,746,000 after acquiring an additional 832,614 shares during the period. Capital International Investors boosted its position in UnitedHealth Group by 4.3% during the 4th quarter. Capital International Investors now owns 19,342,468 shares of the healthcare conglomerate’s stock worth $9,713,058,000 after acquiring an additional 790,219 shares during the period. Finally, Allspring Global Investments Holdings LLC acquired a new position in UnitedHealth Group during the 4th quarter valued at about $346,859,000. Institutional investors and hedge funds own 87.48% of the company’s stock.

In other news, Director Richard T. Burke sold 2,500 shares of the company’s stock in a transaction that occurred on Thursday, May 19th. The stock was sold at an average price of $478.96, for a total transaction of $1,197,400.00. Following the completion of the transaction, the director now directly owns 1,215,000 shares in the company, valued at $581,936,400. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Frederick William Mcnabb III purchased 89 shares of the business’s stock in a transaction dated Thursday, May 26th. The shares were acquired at an average price of $504.32 per share, with a total value of $44,884.48. Following the completion of the acquisition, the director now owns 11,259 shares of the company’s stock, valued at $5,678,138.88. The disclosure for this purchase can be found here. 0.40% of the stock is currently owned by insiders.

UNH has been the subject of a number of research reports. Morgan Stanley increased their price target on UnitedHealth Group from $570.00 to $577.00 and gave the company an “overweight” rating in a research note on Monday, April 18th. Loop Capital began coverage on UnitedHealth Group in a report on Thursday, June 16th. They set a “buy” rating and a $575.00 target price on the stock. StockNews.com began coverage on shares of UnitedHealth Group in a research report on Thursday, March 31st. They issued a “strong-buy” rating on the stock. Raymond James boosted their price target on shares of UnitedHealth Group from $540.00 to $620.00 and gave the stock a “strong-buy” rating in a research report on Tuesday, April 19th. Finally, Royal Bank of Canada set a $563.00 price target on shares of UnitedHealth Group and gave the stock an “outperform” rating in a research report on Monday, April 18th. Three research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $555.73.

NYSE:UNH opened at $489.68 on Thursday. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.78 and a quick ratio of 0.78. UnitedHealth Group Incorporated has a fifty-two week low of $383.12 and a fifty-two week high of $553.29. The stock’s 50-day moving average is $496.56 and its two-hundred day moving average is $490.86. The stock has a market cap of $459.40 billion, a PE ratio of 26.80, a price-to-earnings-growth ratio of 1.41 and a beta of 0.83.

UnitedHealth Group (NYSE:UNHGet Rating) last announced its quarterly earnings results on Thursday, April 14th. The healthcare conglomerate reported $5.49 EPS for the quarter, beating the consensus estimate of $5.40 by $0.09. The business had revenue of $80.15 billion during the quarter, compared to analysts’ expectations of $78.77 billion. UnitedHealth Group had a return on equity of 24.74% and a net margin of 5.86%. The firm’s quarterly revenue was up 14.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $5.31 EPS. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 21.75 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 28th. Investors of record on Monday, June 20th will be paid a $1.65 dividend. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.45. The ex-dividend date of this dividend is Thursday, June 16th. This represents a $6.60 annualized dividend and a dividend yield of 1.35%. UnitedHealth Group’s payout ratio is presently 36.12%.

UnitedHealth Group Company Profile (Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.